U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H23NO.ClH
Molecular Weight 269.81
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEPTAZINOL HYDROCHLORIDE

SMILES

Cl.CCC1(CCCCN(C)C1)C2=CC(O)=CC=C2

InChI

InChIKey=MPJUSISYVXABBH-UHFFFAOYSA-N
InChI=1S/C15H23NO.ClH/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13;/h6-8,11,17H,3-5,9-10,12H2,1-2H3;1H

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: http://www.shijiebiaopin.net/upload/product/201222217302623.PDF | https://www.drugs.com/uk/meptid-tablets-200mg-leaflet.html

Meptazinol is a unique opioid analgesic. Binding studies suggest a relative selectivity for mu-1 opioid receptor sites. Meptid is indicated for the treatment of moderate to severe pain, including post-operative pain, obstetric pain and the pain of renal colic. The most commonly reported adverse reactions after treatment with meptazinol are nausea, vomiting, dizziness, diarrhoea and increased sweating, constipation, abdominal pain, rash, vertigo, headache, drowsiness, somnolence and dyspepsia.

Originator

Curator's Comment: # Wyeth John & Brother Ltd.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P81908
Gene ID: NA
Gene Symbol: BCHE
Target Organism: Equus caballus (Horse)
3.6 µM [IC50]
0.4 µM [IC50]
8.0 nM [Kd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Meptid

Approved Use

The drug is indicated for the treatment of moderate to severe pain, including post-operative pain, obstetric pain and the pain of renal colic.
Primary
Meptid

Approved Use

The drug is indicated for the treatment of moderate to severe pain, including post-operative pain, obstetric pain and the pain of renal colic.
Primary
Meptid

Approved Use

The drug is indicated for the treatment of moderate to severe pain, including post-operative pain, obstetric pain and the pain of renal colic.
PubMed

PubMed

TitleDatePubMed
Enhancement of systemic and CNS delivery of meptazinol hydrochloride by intranasal administration to rats.
2005 Aug
Pharmacokinetic behavior in plasma, cerebrospinal fluid and cerebral cortex after intranasal administration of hydrochloride meptazinol.
2005 Sep 30
[Patient-controlled intravenous analgesia with remifentanil as an alternative to epidural analgesia during labor: case series and discussion of medicolegal aspects].
2010 Aug
Patents

Patents

Sample Use Guides

Oral: One tablet (200 mg), with a glass of water, every four hours. Intramuscular: 75-100mg. The injection may be repeated 2-4 hourly as required. For obstetric pain a dose of 100-150mg should be used according to weight. This dose should approximate 2mg/kg. Intravenous: 50-100mg by slow intravenous injection. The injection may be repeated 2-4 hourly as required. If vomiting occurs, a suitable antiemetic should be given.
Route of Administration: Other
In Vitro Use Guide
Approximately 20 to 40% of 3H-opiate binding is inhibited by meptazinol at concentrations less than 5 nM, whereas the inhibition for D-[3H]Ala2-D-Leu5-enkaphalin usually ranges from 15 to 20%.
Name Type Language
MEPTAZINOL HYDROCHLORIDE
MART.   MI   USAN   WHO-DD  
USAN  
Official Name English
MEPTAZINOL HYDROCHLORIDE [USAN]
Common Name English
WY 22811 HCL
Code English
MEPTID
Brand Name English
PHENOL, 3-(3-ETHYLHEXAHYDRO-1-METHYL-1H-AZEPIN-3-YL)-, HYDROCHLORIDE (1:1)
Systematic Name English
MEPTAZINOL HCL
Common Name English
WY-22811 HYDROCHLORIDE
Code English
IL-22811 HYDROCHLORIDE
Code English
IL-22811 HCL
Code English
MEPTAZINOL HYDROCHLORIDE [MI]
Common Name English
MEPTAZINOL HYDROCHLORIDE [MART.]
Common Name English
MEPTAZINOL HYDROCHLORIDE (±)-
Common Name English
IL 22811 HCL
Code English
WY-22811
Code English
Meptazinol hydrochloride [WHO-DD]
Common Name English
WY-22811 HCL
Code English
Classification Tree Code System Code
NCI_THESAURUS C67413
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
Code System Code Type Description
SMS_ID
100000086403
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
CAS
59263-76-2
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
FDA UNII
T62FQ4ZCPA
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
USAN
W-42
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
RXCUI
11347
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY RxNorm
PUBCHEM
65483
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
NCI_THESAURUS
C87361
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
EVMPD
SUB03161MIG
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
MERCK INDEX
m7200
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
261-683-0
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
EPA CompTox
DTXSID3045485
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY
ChEMBL
CHEMBL314437
Created by admin on Sat Dec 16 07:32:49 GMT 2023 , Edited by admin on Sat Dec 16 07:32:49 GMT 2023
PRIMARY